SCHEMBL5043806

SCHEMBL5043806

CCC(OCC(=O)N(C)OC)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 3/20 0.49
▸ SLC6A3 Q01959 3/20 0.49
▸ SLC6A2 P23975 2/20 0.49
▸ ALDH1A1 P00352 1/20 0.41
▸ ALKBH1 Q13686 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TACR1 P25103 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ MMP8 P22894 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ SLC6A9 P48067 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038984 0.79 GLA (0.44) ALDH1A1ALKBH1TSHRKMT2ALMNA
SCHEMBL16673032 0.78 ALDH1A1 (0.48) SLC6A4SLC6A3ALDH1A1TSHRKMT2A
SCHEMBL16672583 0.77 ALDH1A1 (0.49) SLC6A4SLC6A3SLC6A2ALDH1A1TSHR
SCHEMBL5043805 0.75 SLC6A2 (0.45) SLC6A4SLC6A3SLC6A2KMT2AKCNH2
SCHEMBL362624 0.74 TDP1 (0.56) SLC6A4SLC6A3SLC6A2TDP1KMT2A
SCHEMBL3408278 0.73 LMNA (0.46) SLC6A4SLC6A3SLC6A2ALDH1A1TSHR
SCHEMBL27389987 0.73 LMNA (0.46) SLC6A4SLC6A3SLC6A2ALDH1A1TSHR
SCHEMBL16672576 0.73 ESR1 (0.44) ALDH1A1ALKBH1KMT2AGAALMNA
SCHEMBL8358798 0.72 AOC3 (0.48) SLC6A4SLC6A3SLC6A2TDP1KMT2A
SCHEMBL7681247 0.72 LTB4R (0.51) SLC6A4SLC6A3SLC6A2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1677745-A4 NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS RENOVIS INC (US) 2008-10-22 — — EP disclosed
EP-1677745-A2 NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS Renovis, Inc. (US) 2006-07-12 — — EP disclosed
WO-2005037208-A2 NITRONE COMPOUNDS PRODRUGS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME TO TREAT HUMAN DISORDERS RENOVIS, INC. (US) 2005-04-28 — — WO disclosed
Send feedback